| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $1.0M | +57.9% |
| SG&A Expense | $276K | +134.9% |
| Operating Income | -$5.5M | +50.5% |
| Pre-tax Income | -$5.5M | +54.2% |
| Net Income | -$5.5M | +54.2% |
| EPS (Basic) | -$3.45 | +79.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $225K | -85.0% |
| Current Assets | $365K | -78.2% |
| Total Assets | $365K | -78.2% |
| Current Liabilities | $1.6M | +13.4% |
| Total Liabilities | $1.6M | +13.4% |
| Stockholders' Equity | -$1.9M | -364.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.7M | -53.3% |
| Financing Cash Flow | $1.4M | -55.9% |